Nadja Meumann

412 total citations
8 papers, 275 citations indexed

About

Nadja Meumann is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Nadja Meumann has authored 8 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Genetics and 1 paper in Infectious Diseases. Recurrent topics in Nadja Meumann's work include Virus-based gene therapy research (6 papers), CRISPR and Genetic Engineering (4 papers) and RNA Interference and Gene Delivery (2 papers). Nadja Meumann is often cited by papers focused on Virus-based gene therapy research (6 papers), CRISPR and Genetic Engineering (4 papers) and RNA Interference and Gene Delivery (2 papers). Nadja Meumann collaborates with scholars based in Germany, United States and Spain. Nadja Meumann's co-authors include Hildegard Büning, Ulrich Hacker, Liang Zhang, Anke Huber, Axel Rossi, Laurence M. Occelli, Christian Schön, Ryan F. Boyd, Joshua T. Bartoe and Siegfried Priglinger and has published in prestigious journals such as Molecular Therapy, Cancers and Human Gene Therapy.

In The Last Decade

Nadja Meumann

8 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadja Meumann Germany 8 203 166 48 29 22 8 275
Mickaël Guilbaud France 9 228 1.1× 224 1.3× 66 1.4× 27 0.9× 42 1.9× 19 319
Sophia H.Y. Liao Australia 10 230 1.1× 245 1.5× 57 1.2× 19 0.7× 23 1.0× 11 311
Anja Geisler Germany 10 255 1.3× 195 1.2× 49 1.0× 32 1.1× 89 4.0× 15 364
Alexandria M. Doerfler United States 7 291 1.4× 132 0.8× 43 0.9× 29 1.0× 66 3.0× 8 367
Delphine Briot France 7 358 1.8× 222 1.3× 59 1.2× 22 0.8× 17 0.8× 7 406
Guo-jie Ye United States 5 257 1.3× 251 1.5× 88 1.8× 16 0.6× 40 1.8× 9 362
Monika Ringdal Norway 5 142 0.7× 223 1.3× 23 0.5× 130 4.5× 6 0.3× 6 447
Mengqun Tan China 11 436 2.1× 410 2.5× 81 1.7× 42 1.4× 57 2.6× 20 524
Samita Kafle United States 4 230 1.1× 204 1.2× 72 1.5× 16 0.6× 17 0.8× 6 331
Daniel K. Oh United States 9 264 1.3× 217 1.3× 61 1.3× 14 0.5× 54 2.5× 10 359

Countries citing papers authored by Nadja Meumann

Since Specialization
Citations

This map shows the geographic impact of Nadja Meumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadja Meumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadja Meumann more than expected).

Fields of papers citing papers by Nadja Meumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadja Meumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadja Meumann. The network helps show where Nadja Meumann may publish in the future.

Co-authorship network of co-authors of Nadja Meumann

This figure shows the co-authorship network connecting the top 25 collaborators of Nadja Meumann. A scholar is included among the top collaborators of Nadja Meumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadja Meumann. Nadja Meumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Meumann, Nadja, Christian Schmithals, Tanja Hansen, et al.. (2022). Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors. Cancers. 14(2). 427–427. 7 indexed citations
2.
Bär, Christian, Sonja Groß, Axel Rossi, et al.. (2022). AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes. Molecular Therapy. 30(12). 3601–3618. 28 indexed citations
3.
Pavlou, Marina, Christian Schön, Laurence M. Occelli, et al.. (2021). Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders. EMBO Molecular Medicine. 13(4). e13392–e13392. 80 indexed citations
4.
Meumann, Nadja, et al.. (2020). Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy. Expert Opinion on Biological Therapy. 21(6). 1–18. 16 indexed citations
5.
Vièyres, Gabrielle, Nadja Meumann, Hildegard Büning, et al.. (2020). Controlled Functional Zonation of Hepatocytes In Vitro by Engineering of Wnt Signaling. ACS Synthetic Biology. 9(7). 1638–1649. 9 indexed citations
6.
Rossi, Axel, Nadja Meumann, Kathleen A. Christie, et al.. (2019). Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells. Human Gene Therapy. 30(10). 1284–1296. 22 indexed citations
7.
Büning, Hildegard, Anke Huber, Liang Zhang, Nadja Meumann, & Ulrich Hacker. (2015). Engineering the AAV capsid to optimize vector–host-interactions. Current Opinion in Pharmacology. 24. 94–104. 86 indexed citations
8.
Vogt, Annabelle, Elisabeth Sievers, Veronika Lukacs‐Kornek, et al.. (2013). Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL‐12 in vivo. Liver International. 34(3). 447–461. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026